Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese Community
NCT ID: NCT02914899
Last Updated: 2025-11-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
99 participants
INTERVENTIONAL
2016-08-01
2025-11-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Community-Based Engagement to Improve Lung Cancer Screening and Outcomes: The "Our Lungs Our Health" Study
NCT06909981
Evaluating Shared Decision-Making for Lung Cancer Screening Among Chinese Populations in the United States
NCT05024955
Lung Cancer Screening: A Multilevel Intervention
NCT03862001
Enhancing Lung Cancer Screening Through Human-Centered Intervention
NCT06351085
Bronchoscopy Screening for High-risk Population of Lung Cancer With Severe Smoking With Negative LDCT Screen
NCT04413669
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pilot RCT Control Group
Eligible NYC Chinese livery drivers will receive written materials only
Surveys
Intake surveys recorded demographics, workplace profile, financial profile, health care access, cancer screening behavior, medical history, etc.
Exit surveys asked whether drivers received shared decision making (SDM) counseling, completed LCS (low-dose computed tomography \[LDCT\] scan), had barriers, felt satisfied, etc.
Pilot RCT CHW Intervention Group
Eligible NYC Chinese livery drivers will receive written materials and navigation for shared decision making (SDM) and lung cancer screening (LCS).
Surveys
Intake surveys recorded demographics, workplace profile, financial profile, health care access, cancer screening behavior, medical history, etc.
Exit surveys asked whether drivers received shared decision making (SDM) counseling, completed LCS (low-dose computed tomography \[LDCT\] scan), had barriers, felt satisfied, etc.
Navigation
CHWs facilitated SDM and LCS for drivers, providing navigation ( finding a PCP, scheduling appointments, assisting with insurance, etc.), following up on results and next steps.
Focus Group
The investigators conducted a series of 4-6 focus groups with Chinese livery drivers who (currently, or in the past) smoke.
Focus groups
Gained drivers' perspectives on adapting the community health worker (CHW) model to facilitate lung cancer screening (LCS).
In-Depth Interview Group
12-15 in-depth interviews with livery base management and staff, and with 12-15 primary care physicians (PCPs), clinic directors, hospital CFOs, heads of financial services and counseling, and heads of radiology facilities serving the Chinese community.
In-depth interviews
Interviews with Chinese livery bases elicited perspectives on adapting the CWH model for the drivers' occupational environment.
Interviews with PCPs, clinic directors, etc. serving Chinese communities provided insight into adapting the CHW model within the health care context.
Pre-pilot Group
Approximately 10 Chinese livery drivers who smoke or who quit smoking with the past 15 years and have a 30 pack-year history of smoking
Surveys
Intake surveys recorded demographics, workplace profile, financial profile, health care access, cancer screening behavior, medical history, etc.
Exit surveys asked whether drivers received shared decision making (SDM) counseling, completed LCS (low-dose computed tomography \[LDCT\] scan), had barriers, felt satisfied, etc.
Navigation
CHWs facilitated SDM and LCS for drivers, providing navigation ( finding a PCP, scheduling appointments, assisting with insurance, etc.), following up on results and next steps.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surveys
Intake surveys recorded demographics, workplace profile, financial profile, health care access, cancer screening behavior, medical history, etc.
Exit surveys asked whether drivers received shared decision making (SDM) counseling, completed LCS (low-dose computed tomography \[LDCT\] scan), had barriers, felt satisfied, etc.
Navigation
CHWs facilitated SDM and LCS for drivers, providing navigation ( finding a PCP, scheduling appointments, assisting with insurance, etc.), following up on results and next steps.
Focus groups
Gained drivers' perspectives on adapting the community health worker (CHW) model to facilitate lung cancer screening (LCS).
In-depth interviews
Interviews with Chinese livery bases elicited perspectives on adapting the CWH model for the drivers' occupational environment.
Interviews with PCPs, clinic directors, etc. serving Chinese communities provided insight into adapting the CHW model within the health care context.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Of Chinese descent
* Non-U.S. born
* Fluent in Mandarin
* Livery driver
* Age 45-80
* Current or past (within 15 years) cigarette smoker (no specific pack year requirement)
In Depth Interview Participants Livery Staff
* Of Chinese descent
* Non-U.S. born
* Fluent in Mandarin
* Livery base owner or employee
* Age ≥ 21
Health Care Providers and Administrators:
* Primary care physician, clinic director, hospital administrator, or radiology facility or department administrator
* Age ≥ 21
* Fluent in English
CHW pre-pilot RCT participants:
* Of Chinese descent
* Fluent in Mandarin
* Male
* Livery driver
* Age 55-80 years old
* Driven for 3 months or longer
* 30 pack year history
* Current smoker or quit within 15 years
* Will not be traveling out of New York Area for more than 1 month in the next 3 months
CHW pilot RCT participants
* Of Chinese descent
* Fluent in Mandarin or Cantonese
* Male
* Professional driver
* Age 50-80 years old
* Driven for 3 months or longer
* Last drove professionally within the last 18 months with plans of returning
* 20 pack year smoking history
* Current smoker or quit within 15 years
* Will not be traveling out of New York Area for more than 3 months in the next 12 months
* Has not completed LDCT in the past year.
Exclusion Criteria
21 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Memorial Sloan Kettering Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer Leng, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Related Links
Access external resources that provide additional context or updates about the study.
Memorial Sloan Kettering Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16-949
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.